🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
4.310
-0.040 (-0.92%)
Nov 20, 2026, 4:00 PM EST - Market closed

Treace Medical Concepts Statistics

Total Valuation

TMCI has a market cap or net worth of $282.56 million. The enterprise value is $317.61 million.

Market Cap282.56M
Enterprise Value 317.61M

Important Dates

The last earnings date was Friday, November 6, 2026, before market open.

Earnings Date Nov 6, 2026
Ex-Dividend Date n/a

Share Statistics

TMCI has 65.56 million shares outstanding. The number of shares has increased by 2.95% in one year.

Current Share Class 65.56M
Shares Outstanding 65.56M
Shares Change (YoY) +2.95%
Shares Change (QoQ) +0.64%
Owned by Insiders (%) 26.23%
Owned by Institutions (%) 39.25%
Float 48.37M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.39
Forward PS 1.30
PB Ratio 4.58
P/TBV Ratio 6.66
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.56
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.58, with a Debt / Equity ratio of 1.21.

Current Ratio 2.58
Quick Ratio 1.53
Debt / Equity 1.21
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -8.17

Financial Efficiency

Return on equity (ROE) is -73.98% and return on invested capital (ROIC) is -20.93%.

Return on Equity (ROE) -73.98%
Return on Assets (ROA) -16.49%
Return on Invested Capital (ROIC) -20.93%
Return on Capital Employed (ROCE) -37.22%
Weighted Average Cost of Capital (WACC) 11.50%
Revenue Per Employee $451,880
Profits Per Employee -$123,987
Employee Count450
Asset Turnover 1.08
Inventory Turnover 0.99

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +58.46% in the last 52 weeks. The beta is 1.56, so TMCI's price volatility has been higher than the market average.

Beta (5Y) 1.56
52-Week Price Change +58.46%
50-Day Moving Average 4.41
200-Day Moving Average 3.40
Relative Strength Index (RSI) 46.14
Average Volume (20 Days) 344,597

Short Selling Information

The latest short interest is 1.79 million, so 2.73% of the outstanding shares have been sold short.

Short Interest 1.79M
Short Previous Month 1.92M
Short % of Shares Out 2.73%
Short % of Float 3.70%
Short Ratio (days to cover) 8.19

Income Statement

In the last 12 months, TMCI had revenue of $203.35 million and -$55.79 million in losses. Loss per share was -$0.86.

Revenue203.35M
Gross Profit 161.77M
Operating Income -49.58M
Pretax Income -55.79M
Net Income -55.79M
EBITDA -42.95M
EBIT -49.58M
Loss Per Share -$0.86
Full Income Statement

Balance Sheet

The company has $39.80 million in cash and $74.85 million in debt, with a net cash position of -$35.05 million or -$0.53 per share.

Cash & Cash Equivalents 39.80M
Total Debt 74.85M
Net Cash -35.05M
Net Cash Per Share -$0.53
Equity (Book Value) 61.65M
Book Value Per Share 0.94
Working Capital 72.61M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$8.74 million and capital expenditures -$9.83 million, giving a free cash flow of -$18.57 million.

Operating Cash Flow -8.74M
Capital Expenditures -9.83M
Depreciation & Amortization 6.63M
Net Borrowing 2.90M
Free Cash Flow -18.57M
FCF Per Share -$0.28
Full Cash Flow Statement

Margins

Gross margin is 79.55%, with operating and profit margins of -24.38% and -27.44%.

Gross Margin 79.55%
Operating Margin -24.38%
Pretax Margin -27.44%
Profit Margin -27.44%
EBITDA Margin -21.12%
EBIT Margin -24.38%
FCF Margin n/a

Dividends & Yields

TMCI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -2.95%
Shareholder Yield -2.95%
Earnings Yield -19.99%
FCF Yield -6.57%

Analyst Forecast

The average price target for TMCI is $6.17, which is 43.09% higher than the current price. The consensus rating is "Buy".

Price Target $6.17
Price Target Difference 43.09%
Analyst Consensus Buy
Analyst Count 5
Revenue Growth Forecast (3Y) 3.32%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

TMCI has an Altman Z-Score of -0.48 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.48
Piotroski F-Score 2